Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses

Neuromyelitis optica (NMO) attacks often are severe, are difficult to treat, and leave residual deficits. Here, we analyzed the frequency, sequence, and efficacy of therapies used for NMO attacks.

[1]  H. Abboud,et al.  Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange , 2016, Multiple sclerosis.

[2]  N. Yoshikawa,et al.  Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase , 2015, Journal of clinical apheresis.

[3]  S. Jarius,et al.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment , 2014, Clinical and experimental immunology.

[4]  T. Kanda,et al.  Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis – 1. Whole group analysis , 2013 .

[5]  F. Paul,et al.  Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS) , 2013, Journal of Neurology.

[6]  T. Friede,et al.  Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease , 2013, Blood Purification.

[7]  Y. Lim,et al.  Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders , 2013, Multiple sclerosis.

[8]  Su-Hyun Kim,et al.  Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels , 2013, Journal of clinical neurology.

[9]  A. Traboulsee,et al.  Treatment of Neuromyelitis Optica: Review and Recommendations. , 2012, Multiple sclerosis and related disorders.

[10]  S. Olindo,et al.  Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. , 2012, Archives of ophthalmology.

[11]  H. Dihazi,et al.  Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis , 2012, Journal of Neuroinflammation.

[12]  P. Cabre,et al.  Plasma Exchange in Severe Attacks of Neuromyelitis Optica , 2012, Multiple sclerosis international.

[13]  F. Paul,et al.  Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients , 2012, Journal of Neuroinflammation.

[14]  E. Mauch,et al.  [Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients]. , 2011, Der Nervenarzt.

[15]  C. Trebst,et al.  Immunoadsorption Therapy for Steroid-Unresponsive Relapses in Patients with Multiple Sclerosis , 2011, Blood Purification.

[16]  B. Erickson,et al.  Beneficial plasma exchange response in central nervous system inflammatory demyelination. , 2011, Archives of neurology.

[17]  R. Klingel,et al.  Immunadsorption bei steroidrefraktärem Schub der Multiplen Sklerose , 2011, Der Nervenarzt.

[18]  S. Schippling,et al.  Diagnostik und Therapie der Neuromyelitis optica , 2011, Der Nervenarzt.

[19]  Shuu-Jiun Wang,et al.  The rescue effect of plasma exchange for neuromyelitis optica , 2011, Journal of Clinical Neuroscience.

[20]  C. Trebst,et al.  Diagnostik und Therapie der Neuromyelitis optica , 2011, Der Nervenarzt.

[21]  X. Montalban,et al.  EFNS guidelines on diagnosis and management of neuromyelitis optica , 2010, European journal of neurology.

[22]  Matias D. Cattaneo,et al.  Efficient semiparametric estimation of multi-valued treatment effects under ignorability , 2010 .

[23]  T. Nakazawa,et al.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[24]  X. Montalban,et al.  Plasma exchange for acute attacks of CNS demyelination , 2009, Neurology.

[25]  C. Trebst,et al.  Plasma Exchange Therapy in Steroid-Unresponsive Relapses in Patients with Multiple Sclerosis , 2009, Blood Purification.

[26]  S. Olindo,et al.  Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder , 2009, Multiple sclerosis.

[27]  B. Weinshenker,et al.  The spectrum of neuromyelitis optica , 2007, The Lancet Neurology.

[28]  Y. Itoyama,et al.  Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica , 2007, Multiple sclerosis.

[29]  B. Weinshenker,et al.  Revised diagnostic criteria for neuromyelitis optica , 2006, Neurology.

[30]  B. Weinshenker,et al.  Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange , 2005, The Lancet.

[31]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[32]  R. Gold,et al.  Plasma exchange for severe optic neuritis , 2004, Neurology.

[33]  Andreas Ziegler,et al.  Generalized Estimating Equations in Controlled Clinical Trials: Hypotheses Testing , 2004 .

[34]  B. Weinshenker,et al.  Plasma exchange for severe attacks of CNS demyelination: Predictors of response , 2002, Neurology.

[35]  B. Weinshenker,et al.  A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease , 1999, Annals of neurology.